Your browser doesn't support javascript.
loading
Improving the Quality of Cancer Care in Community Hospitals.
Tucker, Thomas C; Charlton, Mary E; Schroeder, Mary C; Jacob, Jason; Tolle, Cheri L; Evers, B Mark; Mullett, Timothy W.
Afiliación
  • Tucker TC; Markey Cancer Center, Cancer Prevention and Control Program, University of Kentucky, Lexington, KY, USA. thomas.tucker@uky.edu.
  • Charlton ME; Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY, USA. thomas.tucker@uky.edu.
  • Schroeder MC; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
  • Jacob J; Department of Epidemiology, University of Iowa, Iowa City, IA, USA.
  • Tolle CL; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.
  • Evers BM; Division of Health Services Research, College of Pharmacy, University of Iowa, Iowa City, IA, USA.
  • Mullett TW; Markey Cancer Center, Cancer Prevention and Control Program, University of Kentucky, Lexington, KY, USA.
Ann Surg Oncol ; 28(2): 632-638, 2021 Feb.
Article en En | MEDLINE | ID: mdl-32712893
ABSTRACT

BACKGROUND:

Cancer patients treated in community hospitals receive less guideline-recommended care and experience poorer outcomes than those treated in academic medical centers or National Cancer Institute-Designated Cancer Centers. The Markey Cancer Center Affiliate Network (MCCAN) was designed to address this issue in Kentucky, the state with the highest cancer incidence and mortality rates in the U.S.

METHODS:

Using data obtained from the Kentucky Cancer Registry, the study evaluated the impact of patients treated in MCCAN hospitals on four evidence-based Commission on Cancer (CoC) quality measures using a before-and-after matched-cohort study design. Each group included 13 hospitals matched for bed size, cancer patient volume, community population, and region (Appalachian vs. non-Appalachian). Compliance with quality measures was assessed for the 3 years before the hospital joined MCCAN (T1) and the 3 years afterward (T2).

RESULTS:

In T1, the control hospitals demonstrated greater compliance with two quality measures than the MCCAN hospitals. In T2, the MCCAN hospitals achieved greater compliance in three measures than the control hospitals. From T1 to T2, the MCCAN hospitals significantly increased compliance on three measures (vs. 1 measure for the control hospitals). Although most of the hospitals were not accredited by the CoC in T1, 92% of the MCCAN hospitals had achieved accreditation by the end of T2 compared with 23% of the control hospitals.

CONCLUSION:

After the MCCAN hospitals joined the Network, their compliance with quality measures and achievement of CoC accreditation increased significantly compared with the control hospitals. The unique academic/community-collaboration model provided by MCCAN was able to make a significant impact on improvement of cancer care. Future research is needed to adapt and evaluate similar interventions in other states and regions.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hospitales Comunitarios / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hospitales Comunitarios / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos